TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3
Journal of Clinical Investigation · 02.11.2026 · 136 (21)
DOI: 10.1172/jci199525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Minyu Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Carcinoma, Renal Cell, Kidney Neoplasms, Tumor Escape. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) harbors an immunosuppressive tumor microenvironment that facilitates immune evasion and resistance to immune checkpoint blockade (ICB). However, the factors driving immune escape in RCC remain incompletely understood. In this study, transactivation response RNA-binding protein 2 (TARBP2) was identified as a critical regulator of the immune checkpoint molecule B7-H3. Elevated TARBP2 expression was associated with poor prognosis and ICB resistance in patients with RCC. Functionally, TARBP2 in RCC cells suppressed the intratumoral accumulation and cytotoxicity of T cells, particularly NK cells, thereby promoting immune escape. Mechanistically, nuclear TARBP2 interacted with p53-binding protein 1 (53BP1), inhibiting 53BP1 phase separation and subsequent p53 activation, thereby augmenting B7-H3 transcription. Furthermore, TARBP2 inhibition significantly enhanced ICB efficacy when combined with adoptive NK cell therapy. Collectively, these findings establish TARBP2 as a key mediator of immune evasion in RCC and a promising therapeutic target for overcoming ICB resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Department of Urology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Urology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.
- Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Oncology and Southwest Cancer Center, Southwest Hospital of The Third Military Medical University (Army Medical University), Chongqing, China.
- Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of Guangdong Province
- Medical Scientific Research Foundation of Guangdong Province of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, M., Lin, M., Zhu, J., Liu, K., Shu, G., Tong, Z., Zhou, M., Fu, L., Yang, T., Pan, Y., Zhou, X., Luo, J., Liao, W., Li, Q., Liao, L., Lin, H., Huang, K., Zhang, L., Chen, W., …, & Zhang, J. (2026). TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci199525
Vancouver
Chen M, Lin M, Zhu J, Liu K, Shu G, Tong Z, et al. TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci199525
BibTeX
@article{Chen2026,
author = {Chen, Minyu and Lin, Mingjie and Zhu, Jiangquan and Liu, Kezhi and Shu, Guannan and Tong, Zhuting and Zhou, Mi and Fu, Liangmin and Yang, Taowei and Pan, Yihui and Zhou, Xinwei and Luo, Jinchen and Liao, Wuyuan and Li, Qihao and Liao, Lican and Lin, Hansen and Huang, Kangbo and Zhang, Lizhen and Chen, Wei and Luo, Junhang and Zhang, Jiaxing},
title = {TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {21},
doi = {10.1172/jci199525}
}
EUVIMED